Moreover, the study unearthed noteworthy associations between deviant POLD4 expression and an array of factors, encompassing the tumor microenvironment, efficacy of immunotherapy, drug sensitivity, and glioma cell proliferation (Figure 15). The gene discussed is POLD4; the disease is central nervous system cancer.